M. Aaløkken

Subclinical ILD is frequent and progresses across different connective tissue diseases

H. Andersson, Ø. Molberg, Ø. Midtvedt, 2021, ILD / DPLD of known origin.

THU0407 Evaluation of soluble and membrane hla-g in patients with systemic sclerosis and role of these molecules in the pathogenesis of the disease

Ø. Molberg, A. Hoffmann-Vold, Ø. Midtvedt, 2018, THURSDAY, 14 JUNE 2018:.